Sign in
CompletedNo phase

Testing a Causal Model of Cognitive Control Deficits in Posttraumatic Stress Disorder (PTSD)

Key facts

Who runs it
Florida State University
Where
Tallahassee, United StatesSee the site
Trial code
Status
Completed
People taking part
40 people enrolled
Started
13 Sept 2023
Ended
3 Feb 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcranial Magnetic Stimulation (TMS)
Record updated
15 April 2024

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Over 18 years of age
  • Endorse lifetime exposure to at least one Criterion A traumatic event
  • Report clinically significant posttraumatic stress disorder (PTSD) symptoms (score of ≥ 33 on the PTSD Checklist for DSM-5 [PCL-5])

Who cannot take part

  • Endorse medical contraindication for neuromodulation (e.g., ferrous metal in head, seizure disorder, brain tumor, stroke, aneurysm, multiple sclerosis, etc.)
  • Report an unstable medical condition or any current medical condition that precludes safe participation in the trial (e.g., unstable metabolic abnormality, unstable angina, etc.)
  • Report any history or diagnosis of dementia or other cognitive disorder, which may interfere with engagement
  • Report any history or diagnosis of Schizophrenia, Schizoaffective Disorder, Delusional Disorder or other psychotic illness, which precludes safe participation in the trial
  • Report a primary obsessive-compulsive disorder (OCD) diagnosis
  • Report an active substance use disorder (within last 3 months) or any current substance use that precludes safe participation in the trial
  • Report an inability to stop taking any medication that significantly lowers the seizure threshold (e.g., tricyclic antidepressants, clozapine, etc.)
  • Report any history or diagnosis of Severe Traumatic Brain Injury
  • Report suicide risk that precludes safe participation in the trial, defined as clinical impression that the participant is at significant risk for suicide (i.e., greater than moderate level of suicide risk, in accordance with the Joiner et al. (1999) suicide risk framework)
  • Report a current, planned, or suspected pregnancy

Where in United States

  • Florida State University College of MedicineTallahassee, United States

About the trial

What the trial wants to find out

Testing a Causal Model of Cognitive Control Deficits in Posttraumatic Stress Disorder (PTSD)

The 2 groups in the trial

  • Intermittent theta burst stimulation to right dorsolateral prefrontal cortexTreatment being tested

    Participants will receive intermittent theta burst stimulation (iTBS) to the experimental target area, the right dorsolateral prefrontal cortex (rDLPFC)

    Treatment: Transcranial Magnetic Stimulation (TMS)

  • Intermittent theta burst stimulation to vertex of the skullExisting treatment, for comparison

    Participants will receive intermittent theta burst stimulation (iTBS) to the active comparator area, the vertex of the skull

    Treatment: Transcranial Magnetic Stimulation (TMS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
15 April 2024